Introduction
Zygomycosis is an uncommon opportunistic infection seen predominantly in immunosuppressed patients and those with chronic diseases. Infection in immunocompetent patients is rare but mortality from disseminated infection is high. We report a previously fit road traffic accident victim who sustained long bone and facial fractures and then developed life-threatening invasive musculo-cutaneous zygomycosis caused by Rhizopus species.
Case report
A 60-year-old van driver was transferred to the intensive care unit for management of multiple traumatic injuries sustained during a high speed collision with an agricultural vehicle carrying a load of hay. He was known to have ischaemic heart disease and had undergone coronary artery bypass grafting two years previously. His injuries included: a Le Forte Type 3 facial fracture; avulsion of the tip of the C7 transverse process; leftsided rib fractures (ribs 1 to 7) causing a haemo-pneumothorax; fracture dislocation of the right hip; and a grossly comminuted fracture of the right distal femoral shaft. There was also a comminuted fracture of the left tibia and a fracture-dislocation of the right elbow. Emergency surgery was performed at the admitting hospital to stabilise the fractures and after four days he was transferred to the intensive care unit at the Royal Liverpool University Hospital for specialised trauma care.
Further corrective orthopaedic surgery was delayed because of severe lung injury requiring high inspired oxygen concentrations. After five days when the lung injury had settled, further debridement and internal fixation of right hip and ankle, left tibia and right elbow were performed.
Fourteen days after injury, he developed signs of sepsis. Blood cultures taken at this time grew lactose-fermenting coliforms which were sensitive to meropenem. Unfortunately the patient failed to respond to antibiotics and developed necrosis of his forearm, which was initially treated by aggressive debridement. The necrosis progressed and his right arm was amputated above the elbow. The patient was subsequently listed for surgery for his facial fractures but on the day of surgery, tissue samples reported growth of a Rhizopus species. His facial surgery was postponed due to the known predilection of Rhizopus for the sinuses and possible dissemination during a major surgical intervention. Amphotericin B (450 mg once a day) was started but the patient remained septic, became anuric and renal replacement therapy was initiated.
Skin swabs from a number of wound sites were positive for Rhizopus and further debridement of the right arm stump, right lower leg, left leg and right thigh wounds was performed. Rhizopus species were identified in all tissue samples after two weeks of starting amphotericin B. On microbiological advice, posaconazole (400 mg twice a day) was added to the amphotericin B. The wounds were reviewed daily and swabs done regularly. The patient' s HIV test was negative and he gradually improved, with recovering renal function. Amphotericin B was continued for 36 days and posaconazole for 22 days before all wound swabs were negative for fungal growth. He was discharged from intensive care 74 days after his injury.
Discussion
Rhizopus species are members of the class Zygomycetes, order Mucorales and are responsible for opportunistic human infections collectively referred to as Zygomycoses. They can cause devastating illness in previously well patients when compared to other filamentous fungi. 1 Mortality varies depending on site of infection and patient co-morbidity. Singlesite infection in patients with no underlying pathology has an overall mortality of 35% but disseminated disease has a mortality of 96%. 2 In health, Rhizopus is killed by both mononuclear and polymorphonuclear phagocytes; 3 patients with deficient phagocyte function or deficient phagocyte numbers are susceptible to zygomycosis. Hyperglycaemia affects phagocyte function, and diabetes is the single most common predisposing factor. Case reports have also implicated hyperglycaemia. 4 Infection has been reported in patients with immunodeficiency and neutropenia, leukaemia, lymphoma, organ and bone marrow transplantation. Patients with chronic renal failure are susceptible, particularly when receiving desferrioxamine (RINN) for iron or aluminium overload. 5 Rhizopus has been found in soil from cultivated land and woodland. 6 It has also been isolated from hay and decaying plant and leaf matter. Our patient contracted Rhizopus from wounds which were heavily contaminated after a collision with
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A 60-year-old man involved in a high-speed collision with a hay wagon was admitted with multiple trauma. He developed life-threatening invasive musculo-cutaneous zygomycosis caused by Rhizopus species, which is found in soil from cultivated land and woodland. A high index of suspicion given the nature of the injury, aggressive surgical debridement and appropriate anti-fungal therapy prevented a fatal outcome.
Keywords: mucormycosis; rhizopus; posaconazole; amphotericin; trauma a hay wagon. Zygomycosis in a previously fit farm worker involved in an accident with contaminated agricultural machinery has been described, but the patient did not survive. 7 The organism is transmitted by spores which are either inhaled, ingested or contaminate wounds. Consequently most Rhizopus infections are found in either the lungs or facial sinuses, reflecting the commonest means of transmission. Luckily for the patient, Rhizopus was detected before planned facial surgery which may have led to systemic dissemination of the fungus and a worsening of his condition.
The classical features of infection with this organism are angio-invasion, thrombosis, infarction and necrosis. 6 Cutaneous disease can be locally invasive and can penetrate fascial compartments leading to invasion of surrounding subcutaneous fat, muscle and bone. Invasion into blood vessels can lead to haematogenous spread and disseminated disease.
Treatment relies on the basic principles of early detection, surgical debridement of infected tissue, especially along myocutaneous and myofascial planes, and appropriate antifungal therapy. Control of predisposing factors, namely maintenance of normoglycaemia, correction of acidaemia and where possible discontinuation of immunosuppression or corticosteroid therapy are also important. 6 In 2005 Roden et al published a major review of zygomycosis in humans, reviewing 929 cases published since 1940. 2 Of the 929 cases, only 176 (19%) had no underlying condition at the time of diagnosis of infection. The overall mortality in this group was 35%. Forty-four patients suffered penetrating trauma; the mortality in this subgroup was 23%. Out of all the previously well patients, the highest mortality was in the subgroup who developed infection after burns (64%). Cutaneous infection was the primary site of infection in half of the patients with no underlying condition. Survival overall was highest in the group of patients treated with a combination of surgical debridement and anti-fungal therapy (70%). A more recent analysis of 230 cases recorded between 2005 and 2007 in the registry of the European Confederation of Medical Mycology Working Group on Zygomycosis has shown that the most common manifestations of zygomycosis were pulmonary (30%), rhino-cerebral (27%), soft tissue (26%) and disseminated disease (15%). 8 Rhizopus was isolated as the major organism in culture-positive cases (34%). Total mortality in the entire cohort was high (47%). Factors associated with survival included treatment with amphotericin B and surgery. Localised non-disseminated cutaneous zygomycosis treated with a combination of aggressive surgical debridement and anti-fungal therapy has a mortality of less than 10%. 3 In a case published in 2005, El Deeb et al advocated early and aggressive surgical debridement. 9 Very few anti-fungal agents have activity against zygomycetes and amphotericin B at the highest tolerated dose remains the mainstay of treatment. Greenberg et al 10 cite increasing resistance to amphotericin and the considerably high mortality as evidence of the need for new drug treatments. In their study they used posaconazole as rescue therapy when seven days of amphotericin had failed to satisfactorily treat zygomycosis. They reported a 79% survival rate (19 out of 24 patients). All of the patients in this study had severe underlying disease associated with their infection. amphotericin B lipid complexes and liposomal formulations exhibit synergistic activity with neutrophils in inducing filament damage to Rhizopus. 11 This may be advantageous in renal impairment as there is no need for dose adjustment with these formulations.
The patient survived his injury but was left with a significant disability, losing his dominant arm above the elbow. Early detection due to a high index of suspicion because of the circumstances of the initial injury, aggressive surgical debridement and amputation, along with timely combination anti-fungal therapy prevented a fatal outcome.
Conclusion
There are a wide number of environmental organisms which may become pathogenic and contamination of wounds at the scene of an injury is an important portal of entry of unusual pathogens. For infections with Rhizopus, early combination therapy with aggressive surgical debridement may be lifesaving.
